Home > Boards > US OTC > Medical - Healthcare > InVivo Therapeutics Holdings Corp (NVIV)

I do not know about that as I

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DDobserver Member Profile
 
Followed By 6
Posts 380
Boards Moderated 0
Alias Born 06/24/14
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/21/2019 4:08:00 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 6/21/2019 8:02:13 AM
InVivo Therapeutics gibt Vertagung der Hauptversammlung bekannt Business Wire - 6/14/2019 1:21:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/14/2019 8:06:21 AM
InVivo Therapeutics Announces Adjournment of Annual Meeting Business Wire - 6/14/2019 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/14/2019 7:51:21 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/5/2019 8:10:45 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/5/2019 8:07:49 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/30/2019 6:01:28 AM
InVivo Therapeutics Announces Enrollment of First Two Patients into the INSPIRE 2.0 Study for the Treatment of Acute Spinal C... Business Wire - 5/29/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/22/2019 5:56:59 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 5/17/2019 4:37:53 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 8:03:06 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/25/2019 5:22:49 PM
InVivo Therapeutics Announces Presentation of Twelve-Month Results from the INSPIRE Study of the Investigational Neuro-Spinal... Business Wire - 4/17/2019 8:00:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 4/15/2019 5:14:37 PM
InVivo Therapeutics Reports 2018 Year-end Financial Results and Provides Business Update Business Wire - 4/1/2019 8:15:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 4/1/2019 8:10:25 AM
Annual Report (10-k) Edgar (US Regulatory) - 4/1/2019 8:04:59 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/20/2019 6:31:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/20/2019 4:13:26 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 1:48:59 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 1:46:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/16/2019 4:43:10 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 1/16/2019 4:41:27 PM
DDobserver   Tuesday, 08/28/18 02:08:00 PM
Re: chuckt880 post# 6077
Post # of 6120 
I do not know about that as I do not have enough fact. What I do know is people who have never been close to paralysis do not understand what this product is capable of.

Imagine if you had the choice of being cloistered in a bed and someone says I have a product that will possibly allow you to live life in a chair or with leg braces. Would you choose the bed or the chair?

Large companies such as Stryker should wake up and realize the opportunity here. I think with time it will become apparent to the market. For now this is a waiting game.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist